Tatva Chintan Pharma Chem Ltd. IPO

It is India’s first and world’s second-largest commercial manufacturer of SDAs for zeolites (used in batteries).

RHP
View
DRHP
View
Open Date

2021-07-16

Close Date

2021-07-20

Tatva Chintan Pharma Chem Ltd. IPO Details

Check out the issue details for Tatva Chintan Pharma Chem Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 1083

Price Band

₹ 1073 - 1083

Issue Size

500 Cr.

Issue Type

Book Built

Open

2021-07-16

Close

2021-07-20

Listingprice

₹ 2111.85

ListingGain

95.00%

Listing Date

2021-07-29

CMP

₹ 824.6

Current Return

-23.86%

Tatva Chintan Pharma Chem Ltd. News

Tatva Chintan Pharma Chem informs about newspaper publication26 Oct, 3:36PM Tatva Chintan Pharma - Quaterly Results25 Oct, 3:50PM Tatva Chintan Pharma - Quaterly Results25 Oct, 3:50PM Tatva Chintan Pharma - Quaterly Results25 Oct, 3:50PM Tatva Chintan Pharma Chem submits board meeting intimation 16 Oct, 5:28PM Tatva Chintan Pharma Chem informs about investors meeting 23 Sep, 2:52PM Tatva Chintan Pharma Chem informs about newspaper advertisement17 Aug, 10:33AM Tatva Chintan Pharma - Quaterly Results24 Jul, 3:39PM Tatva Chintan Pharma - Quaterly Results24 Jul, 3:39PM Tatva Chintan Pharma - Quaterly Results24 Jul, 3:39PM Tatva Chintan Pharma Chem informs about board meeting 16 Jul, 12:03PM Tatva Chintan Pharma Chem informs about analyst meet 22 Jun, 11:05AM Tatva Chintan Pharma Chem submits analyst meet intimation10 Jun, 4:37PM Tatva Chintan Pharma Chem informs about earnings call transcript7 May, 5:16PM Tatva Chintan Pharma - Quaterly Results3 May, 3:41PM Tatva Chintan Pharma - Quaterly Results3 May, 3:41PM Tatva Chintan Pharma - Quaterly Results3 May, 3:41PM Tatva Chintan Pharma Chem submits analyst meet intimation16 Mar, 11:59AM Tatva Chintan Pharma Chem informs about update27 Jan, 4:28PM Tatva Chintan Pharma - Quaterly Results20 Jan, 3:26PM

Company Financials

You can get the following financial statements of Tatva Chintan Pharma Chem Ltd. as of now.

Exchange

NSE: TATVA BSE: 543321

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

The valuation of Tatva Chintan Pharma IPO company based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 1083
Total Shares 2.22 Cr
Market Cap 2404 Cr
EPS  Rs 23.17 
PE Ratio 47x
Industry PE 56x

 

Tatva Chintan Pharma IPO issue size is 500 Cr. 

Issue Amount
Fresh Issue 225 Cr
Offer For Sale 275 Cr

 

An Individual can apply for a minimum 1 lot of 13 shares and a maximum of 14 lots of 182 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 13 Rs 14,079
 Maximum 14 182 Rs 1,97,106

 

Tatva Chintan Pharma IPO is subscribed 180.36 times till 20th July. It is Oversubscribed as of now. The category-wise subscription is as follows:

Category % Offered Subscription 
Qualified Institutional Maximum 50% 185.23 Times
Non-Institutional Minimum 15% 512.22 Times
Retail Individual Minimum 35% 35.53 Times
Total 100% 180.36 Times

Once you have subscribed to an IPO, you have to wait for its allotment to your account. Find below the dates of allotment of Tatva Chintan Pharma IPO:

Schedule Date
Basis of Allotment 26 August 2021
Refunds 27 August 2021
Credit to Demat Account 28 August 2021
IPO Listing Date 29 August 2021

When the allotment is out, you can check it from the registrar's website. Find the Tatva Chintan Pharma IPO allotment status here.

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 253.84 291.19 427.81 403.04 378.68
Total Expenditure 201.14 225.8 321.81 348.23 311.66
Operating Profit 52.7 65.39 106.01 54.82 67.01
Other Income 0.56 5.1 10.63 5.68 7.51
Interest 4.25 4.41 5.19 8.52 6.66
Depreciation 4.79 6.73 8.18 9.55 25.6
Exceptional Items 0 0 0 -3.59 0
Profit Before Tax 44.22 59.35 103.27 38.83 42.27
Provision for Tax 9.25 7.99 7.28 -1.63 12.92
Net Profit 34.96 51.36 95.99 40.47 29.35
Adjusted EPS (Rs.) 1.74 2.56 4.33 1.83 1.25

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 8.04 20.09 22.17 22.17 23.39
Total Reserves 106.41 141.85 446.71 482.62 702.49
Borrowings 38.71 26.76 13.11 4.23 0.64
Other N/C liabilities 4.89 4.06 -8.05 -15.26 -10.96
Current liabilities 87.26 127.08 193.55 246.58 94.56
Total Liabilities 245.31 319.83 667.49 740.34 810.11
Assets
Net Block 111.18 120.45 159.61 196.22 426.87
Capital WIP 4.89 9.81 51.49 230.74 72.93
Intangible WIP 0 0 0 0 3.61
Investments 0.67 0.67 0.67 0.67 0.67
Loans & Advances 0.17 0.3 2.09 2.66 4.26
Other N/C Assets 0 0 0.51 0.55 0.83
Current Assets 128.4 188.61 453.12 309.49 300.95
Total Assets 245.31 319.83 667.49 740.34 810.11
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Other Income 0.76 1.21 4.53 1.42 0.81
Profit Before Tax 11.71 6.56 12.28 2.14 -1.58
Tax 3.5 1.91 4.03 0.63 -0.47
Profit After Tax 8.2 4.65 8.25 1.51 -1.11
Adjusted EPS (Rs) 3.51 1.99 3.53 0.64 -0.47

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 72.02 0
Jun 2024 72.02 0
Mar 2024 72.02 0
Dec 2023 72.02 0
Sep 2023 72.02 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 44.22 59.35 103.27 38.83 42.27
Adjustment 8.2 6.92 9.64 15.82 28.17
Changes in Assets & Liabilities -20.4 -37.55 -75.18 -23.18 40.58
Tax Paid -7.39 -9.82 -17.97 -7.74 -8.24
Operating Cash Flow 24.64 18.91 19.76 23.73 102.78
Investing Cash Flow -40.18 -20.61 -196.72 -101.13 -120.52
Financing Cash Flow 9.7 -4.72 235.01 37.82 30.54
Net Cash Flow -5.85 -6.42 58.05 -39.59 12.8
X